Thomas Grischott
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
- Economics and Econometrics top 10%
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Economic and Financial Impacts of Cancer 3
- Pharmaceutical Economics and Policy 2
-
- Pharmaceutical Practices and Patient Outcomes 4
- Co-authors
- Thomas Rosemann (15 shared papers)Aaron S. Kesselheim (2 shared papers)Kerstin Noëlle Vokinger (2 shared papers)Ariadna Tibau (2 shared papers)Thomas J. Hwang (2 shared papers)Sophie Reichert (1 shared paper)Yael Rachamin (12 shared papers)Stefan Neuner‐Jehle (8 shared papers)
- Journals
- PLoS ONE (3 papers)Swiss Medical Weekly (3 papers)BMJ Open (2 papers)Frontiers in Pharmacology (1 paper)International Journal of Health Policy and Management (1 paper)
- Partner nations
- SwitzerlandUnited StatesSpain
In The Last Decade
Thomas Grischott
22 papers receiving 377 citations
Peers
Comparison fields: 5 of 75
- Geriatrics and Gerontology 32
- Economics and Econometrics 122
- Family Practice 3
- Applied Microbiology and Biotechnology 3
- Health Informatics 2
Countries citing papers authored by Thomas Grischott
This map shows the geographic impact of Thomas Grischott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Grischott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Grischott more than expected).
Fields of papers citing papers by Thomas Grischott
This network shows the impact of papers produced by Thomas Grischott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Grischott. The network helps show where Thomas Grischott may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Grischott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 148 | |
| 2 | 2021 | 55 | |
| 3 | 2017 | 30 | |
| 4 | 2021 | 26 | |
| 5 | 2018 | 15 | |
| 6 | 2019 | 13 | |
| 7 | 2022 | 13 | |
| 8 | 2024 | 13 | |
| 9 | 2018 | 12 | |
| 10 | 2023 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 3 |
About Thomas Grischott
Thomas Grischott is a scholar working on Economics and Econometrics, Geriatrics and Gerontology, General Health Professions, Oncology and Surgery, having authored 28 papers that have together received 385 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Economic and Financial Impacts of Cancer (3 papers), COVID-19 and healthcare impacts (2 papers), Pharmaceutical Economics and Policy (2 papers), Smoking Behavior and Cessation (2 papers), Healthcare cost, quality, practices (2 papers) and Statistical Methods and Inference (1 paper). The work is most often cited by research in Geriatrics and Gerontology (32 citations), Economics and Econometrics (122 citations), Family Practice (3 citations), Applied Microbiology and Biotechnology (3 citations) and Health Informatics (2 citations). Thomas Grischott has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Thomas Rosemann, Aaron S. Kesselheim, Kerstin Noëlle Vokinger, Ariadna Tibau, Thomas J. Hwang, Sophie Reichert, Yael Rachamin, Stefan Neuner‐Jehle, Oliver Senn and Matthias R. Meyer. Their work appears in journals such as PLoS ONE, Swiss Medical Weekly, BMJ Open, Frontiers in Pharmacology and International Journal of Health Policy and Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.